OSE Immunotherapeutics SA

Rachunek Zysków i Strat


Profil spółki
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 74
EBIT TTM (mln): 16
index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Przychód (mln) 0 0 0 0 0 7 24 26 10 26 18 2
Przychód Δ r/r 0.0% 0.0% 0.0% inf% 9475.0% 1644.6% 266.0% 6.1% -59.9% 152.5% -30.4% -87.8%
Marża brutto 0.0% 0.0% 0.0% -225.0% 95.8% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
EBIT (mln) -1 -0 -3 -5 -1 -13 5 -5 -25 -22 -24 -32
EBIT Δ r/r 0.0% -82.7% 1026.0% 92.5% -89.5% 2126.6% -138.4% -204.4% 388.8% -11.2% 9.4% 34.6%
EBIT (%) 0.0% 0.0% 0.0% -135500.0% -148.0% -188.9% 19.8% -19.5% -237.4% -83.5% -131.3% -1452.9%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 1 1 2
EBITDA (mln) -1 -0 -0 -5 -0 -13 5 -5 -24 -19 -20 -29
EBITDA(%) 0.0% 0.0% 0.0% -133025.0% -120.1% -187.1% 20.3% -17.6% -230.4% -73.6% -111.9% -1297.0%
Podatek (mln) 2 0 0 0 3 2 1 0 -8 -5 -6 -6
Zysk Netto (mln) -1 -0 -3 -6 21 -11 5 -5 -17 -17 -18 -23
Zysk netto Δ r/r 0.0% -82.6% 1034.0% 97.0% -470.1% -150.8% -152.3% -184.7% 255.9% 1.8% 5.4% 29.5%
Zysk netto (%) 0.0% 0.0% 0.0% -139600.0% 5395.8% -157.2% 22.4% -17.9% -158.9% -64.1% -97.0% -1032.9%
EPS -0.18 -0.0328 -0.36 -0.59 1.65 -0.73 0.35 -0.31 -1.06 -0.93 -0.96 -1.18
EPS (rozwodnione) -0.18 -0.0328 -0.36 -0.59 1.52 -0.73 0.35 -0.31 -1.06 -0.93 -0.96 -1.18
Ilośc akcji (mln) 8 8 8 9 14 14 16 15 16 18 18 20
Ważona ilośc akcji (mln) 8 8 8 10 14 14 16 15 16 18 18 20
Waluta EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR EUR